NASDAQ:ETON Eton Pharmaceuticals Q3 2026 Earnings Date & Estimates $53.33 -1.92 (-3.48%) Closing price 10/13/2026 04:00 PM EasternExtended Trading$53.53 +0.20 (+0.38%) As of 07:42 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Eton Pharmaceuticals is estimated to report Q3 2026 earnings on Thursday, November 5, 2026, after market closes. The conference call is scheduled for 4:30 PM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 5, 2026TimeAfter Market ClosesConference Call4:30 PM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Eton Pharmaceuticals in Q3 2026Eton Pharmaceuticals is expected to post earnings of $0.3125 per share on revenue of $41.99 million. In the same quarter a year earlier Eton Pharmaceuticals reported -$0.07 per share on revenue of $22.46 million. Eton Pharmaceuticals last reported on August 13, 2026, posting $0.43 per share and beating the $0.1898 consensus estimate. Eton Pharmaceuticals has beaten the consensus EPS estimate in 1 of its last 8 quarters.Consensus EstimatesConsensus EPS$0.3125Expected Revenue$41.99 millionPrior-Year EPS-$0.07Prior-Year Revenue$22.46 millionExpected Revenue Growth+86.9%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS$0.43 (Beat by +$0.2402)Last Quarter Revenue$37.59 millionEPS Beat Rate1 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report Eton Pharmaceuticals Q3 2026 Earnings FAQ When does Eton Pharmaceuticals report Q3 2026 earnings? Eton Pharmaceuticals (NASDAQ:ETON) is estimated to report Q3 2026 earnings on Thursday, November 5, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it. What time is Eton Pharmaceuticals' Q3 2026 earnings call? Eton Pharmaceuticals' Q3 2026 earnings conference call is scheduled for Thursday, November 5, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Eton Pharmaceuticals? Analysts expect Eton Pharmaceuticals to post earnings of $0.3125 per share for Q3 2026. How much revenue is Eton Pharmaceuticals expected to report? The consensus revenue estimate for Eton Pharmaceuticals is $41.99 million for Q3 2026. Eton Pharmaceuticals Earnings HeadlinesEton Pharmaceuticals and Aquestive Therapeutics Announce Exclusive U.S. Licensing Agreement for LIBERVANT® (diazepam) Buccal Film1 hour ago | globenewswire.comEton Pharmaceuticals (NASDAQ:ETON) Stock: Insider David Krempa Sells 4,166 SharesOctober 8, 2026 | americanbankingnews.comFederal Reserve Reveals Disturbing New Plan To Control Your MoneyDocket No. OP-1670 is drawing attention for what it reveals about the Federal Reserve's next move. Buried on page 84 is a plan that could expand oversight of checking accounts, purchases, and money transfers across the country. Martin D. Weiss, PhD, founder of Weiss Ratings, breaks down what this document means and why it could roll out as soon as this summer.October 14 at 1:00 AM | Weiss Ratings (Ad)Analyzing Fortress Biotech (NASDAQ:FBIO) and Eton Pharmaceuticals (NASDAQ:ETON)October 4, 2026 | americanbankingnews.comEton Pharmaceuticals Announces U.S. Commercial Availability of IMPAVIDO(R) (miltefosine) CapsulesSeptember 29, 2026 | marketscreener.comMEton Relaunches IMPAVIDO In U.S., Expands Patient Access ProgramsSeptember 28, 2026 | rttnews.comSee More Eton Pharmaceuticals Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Eton Pharmaceuticals? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Eton Pharmaceuticals and other key companies, straight to your email. Email Address About Eton PharmaceuticalsEton Pharmaceuticals (NASDAQ:ETON) is a specialty pharmaceutical company focused on developing, acquiring, and commercializing treatments for rare diseases and other underserved patient populations. The company’s strategy includes advancing proprietary product candidates and obtaining rights to established medicines that can address unmet medical needs. Eton’s portfolio has included products such as Eprontia (topiramate) oral solution for certain seizure disorders and migraine prevention, Biorphen (phenylephrine hydrochloride) injection for the treatment of clinically important hypotension, and specialty medicines used in the management of rare metabolic and endocrine conditions. Its products are primarily marketed through the U.S. healthcare system. Founded in 2017 and headquartered in Deer Park, Illinois, Eton has built its business through internal product development, licensing arrangements, and acquisitions of pharmaceutical assets. Sean Brynjelsen, the company’s founder, serves as president and chief executive officer.View Eton Pharmaceuticals ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles A Chinese Rival Just Spooked Memory Stocks—How Worried Should Micron Investors Be?Tax Credit Turmoil: Why Enphase and SolarEdge Face a Tough RoadSurgical Precision, Sustainable Returns: Johnson & Johnson Secures Its Cash Flow RunwayJPMorgan Earnings Miss Estimates But Reveal Broad-Based StrengthAmazon's $220 Billion AI Bet Is Getting Bigger—Can Earnings Justify the Spending?A Silent Winner: Texas Instruments Anchors the AI SupercycleDelta's Guidance Cut Could Spell Trouble for the Airline Industry Upcoming Earnings Interactive Brokers Group (10/15/2026)Marsh & McLennan Companies (10/15/2026)The PNC Financial Services Group (10/15/2026)Charles Schwab (10/15/2026)U.S. Bancorp (10/15/2026)Prologis (10/15/2026)Taiwan Semiconductor Manufacturing (10/15/2026)Truist Financial (10/16/2026)Travelers Companies (10/16/2026)HDFC Bank (10/17/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
